A Pilot Study for Optimizing Meropenem Administration in the ICU
A Pilot Study for Optimizing Meropenem Administration in the Intensive Care Unit - Short Six Times vs Prolonged Three Times Courses Daily
Oslo University Hospital
50 participants
Dec 14, 2021
INTERVENTIONAL
Conditions
Summary
Can antibiotic drugs be administered faster and make acceptable serum concentrations if we give short but multiple infusions compared to long and fewer infusions? In this study we will compare giving meropenem 1 gram 6 times daily in 15 minutes infusions to the recommended 2 gram 3 times daily in 3 hours infusions. In patients in the intensive care unit, the need for intravenous access is of essence. If 6 short infusions results in the same serum concentrations as 3 long infusions, we will increase intravenous access from 15 to 22.5 hours daily.
Eligibility
Inclusion Criteria3
- Patients ≥ 18 years admitted to the ICU at Oslo University Hospital, Rikshospitalet and
- who shall be treated with meropenem because of proven or suspected serious infection and
- who give their written informed consent either directly or through next of kin
Exclusion Criteria4
- with known hypersensistivity to betalactam antibiotics or
- who use of valproat or
- who are pregnant or
- the lack of consent.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
given as 6 or 3 infusions in 15 minues or 3 hours.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05578586